Corp /De/ Celgene's Net Worth
Corp /De/ Celgene's net worth is estimated to be at least $128,736,275.98 as of 04/28/2024. CoreStreet's estimation of Corp /De/ Celgene's net worth is based on their sale of stock and current holding of stock.
Corp /De/ Celgene is Major Shareholder at Agios Pharm. They have executed at least 18 trades of stock as per SEC Form 4 filings. Their most recent trade was for 403,225 units of AGIO stock on 11/12/2019. Their biggest sale was on 12/04/2017 when they sold 1,112,446 units of Crispr Therapeutics AG stock for $21,114,225.08. They typically trade 4 times per year.
Total value of insider buys:
- $91,931,493.00
Total value of insider sells:
- $36,804,782.98
Most recent insider trade:
- Nov. 12, 2019
Corp /De/ Celgene's Insider Trading History
| Agios Pharm | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 12, 2019 | Major Shareholder | 403,225 | $31.00 | Buy | $12,499,975.00 |
Jan. 23, 2018 | Major Shareholder | 851,154 | $67.00 | Buy | $57,027,318.00 |
| Crispr Therapeutics AG | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 4, 2017 | Major Shareholder | 1,112,446 | $18.98 | Sell | $21,114,225.08 |
Dec. 1, 2017 | Major Shareholder | 87,991 | $19.10 | Sell | $1,680,628.10 |
Nov. 29, 2017 | Major Shareholder | 4,263 | $19.25 | Sell | $82,062.75 |
Nov. 27, 2017 | Major Shareholder | 27,990 | $19.75 | Sell | $552,802.50 |
Nov. 24, 2017 | Major Shareholder | 26,010 | $20.00 | Sell | $520,200.00 |
Nov. 22, 2017 | Major Shareholder | 256,000 | $19.76 | Sell | $5,058,560.00 |
Nov. 20, 2017 | Major Shareholder | 158,718 | $19.02 | Sell | $3,018,816.36 |
Nov. 17, 2017 | Major Shareholder | 51,282 | $18.44 | Sell | $945,640.08 |
Nov. 15, 2017 | Major Shareholder | 15,000 | $17.67 | Sell | $265,050.00 |
Nov. 13, 2017 | Major Shareholder | 65,093 | $17.76 | Sell | $1,156,051.68 |
Nov. 10, 2017 | Major Shareholder | 10,000 | $17.28 | Sell | $172,800.00 |
Nov. 8, 2017 | Major Shareholder | 16,875 | $18.06 | Sell | $304,762.50 |
Nov. 6, 2017 | Major Shareholder | 79,327 | $18.89 | Sell | $1,498,487.03 |
Nov. 3, 2017 | Major Shareholder | 22,759 | $19.10 | Sell | $434,696.90 |
Oct. 24, 2016 | Major Shareholder | 800,150 | $14.00 | Buy | $11,202,100.00 |
| Bristol-Myers Squibb Company | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 24, 2016 | Major Shareholder | 800,150 | $14.00 | Buy | $11,202,100.00 |